Evidence map›Paper›PMID 36285784›Full record

ArticleJournal of the American Heart Association2022

Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study.

Matthew R Deshotels, Caroline Sun, Vijay Nambi, Salim S Virani, Kunihiro Matsushita, Bing Yu, Christie M Ballantyne, Ron C Hoogeveen

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthew R DeshotelsDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0003-2894-433X
Caroline SunDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0002-3192-0067
Vijay NambiDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0002-4237-0267
Salim S ViraniDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0001-9541-6954
Kunihiro MatsushitaDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD.ORCID 0000-0002-7179-718X
Bing YuDepartment of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health University of Texas Health Science Center Houston TX.ORCID 0000-0003-4818-1077
Christie M BallantyneDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0002-6432-1730
Ron C HoogeveenDepartment of Medicine Baylor College of Medicine Houston TX.ORCID 0000-0003-2399-4653

Funding

NHLBI NIH HHS HHSN268201700001CNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002CNHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003CNHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004CNHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005CNHLBI NIH HHS HHSN268201700005I
6 · The paper itself

Abstract

Background Plasma lipoprotein(a) (Lp[a]) concentrations are primarily determined by genetic factors and are believed to remain stable throughout life. However, data are scarce on longitudinal trends in Lp(a) concentrations over time. Therefore, it is unclear whether measurement of Lp(a) once in a person's life is sufficient for cardiovascular risk assessment in all adults. Methods and Results Lp(a) concentrations, specifically apolipoprotein(a) concentrations, were measured at visits 4 and 5, ≈15 years apart, in 4734 adult participants of the ARIC (Atherosclerosis Risk in Communities) study (mean age at visits 4 and 5, 60.7±5.1 and 75.5±5.2 years, respectively). Participants were categorized by baseline (visit 4) Lp(a) concentrations as normal (<30 mg/dL), borderline-high (30-49 mg/dL), or high (≥50 mg/dL). We compared adults with Lp(a) change ≥20 mg/dL between visits and those with Lp(a) change <20 mg/dL. Multivariable logistic regression analysis was used to identify covariates associated with change in Lp(a) over time. At visit 5, 58.1% of participants with borderline-high Lp(a) concentrations of 30 to 49 mg/dL at visit 4 had high Lp(a) concentrations ≥50 mg/dL. Participants with low Lp(a) (<30 mg/dL) or high Lp(a) (≥50 mg/dL) at visit 4 tended to stay in these respective categories. Black race, female sex, diabetes, hypertension, total cholesterol, and albuminuria were associated with significantly greater probability for Lp(a) change ≥20 mg/dL over time. Conclusions Our results suggest that adults with borderline-high Lp(a) concentrations may be considered for repeat monitoring of Lp(a) over time, particularly if they are Black, women, or have diabetes, hypertension, and/or elevated albuminuria.

Indexed as

AtherosclerosisDiabetes MellitusHypertensionAdultAlbuminuriaBlack PeopleFemaleHumansLipoprotein(a)Risk FactorsLipoprotein(a)lipoprotein(a)risk assessmentrisk factors

Identifiers

PMID36285784
PMCPMC9673625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.